Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

alfasigma s.p.a. - losartan e diuretici - losartan e diuretici

Unione Europea - italiano - EMA (European Medicines Agency)

ucb pharma s.a. - lacosamide - epilessia, parziale - antiepilettici, - lacosamide ucb è indicato come monoterapia e in terapia aggiuntiva nel trattamento di parziale-inizio convulsioni con o senza secondaria generalizzazione in adulti, adolescenti e bambini a partire dai 4 anni di età con epilessia.

Unione Europea - italiano - EMA (European Medicines Agency)

extrovis eu ltd. - lacosamide - epilessia - antiepilettici, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Unione Europea - italiano - EMA (European Medicines Agency)

accord healthcare s.l.u. - lacosamide - epilessia - antiepilettici, - lacosamide accord is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. lacosamide accord is indicated as adjunctive therapy•         in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. •         in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

desitin pharma gmbh - lacosamidum - compresse rivestite con film - lacosamidum 50.00 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, cellulosum microcristallinum silicificatum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, e 171, talcum, e 132, e 172 (rubrum), e 172 (nigrum), pro compresso obducto. - antiepileptikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

desitin pharma gmbh - lacosamidum - compresse rivestite con film - lacosamidum 100.00 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, cellulosum microcristallinum silicificatum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, e 171, talcum, e 172 (flavum), pro compresso obducto. - antiepileptikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

desitin pharma gmbh - lacosamidum - compresse rivestite con film - lacosamidum 150.00 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, cellulosum microcristallinum silicificatum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus) macrogolum 3350, e 171, talcum, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), pro compresso obducto. - antiepileptikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

desitin pharma gmbh - lacosamidum - compresse rivestite con film - lacosamidum 200.00 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, cellulosum microcristallinum silicificatum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171 macrogolum 3350, talcum, e 132, pro compresso obducto. - antiepileptikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

desitin pharma gmbh - lacosamidum - sirup - lacosamidum 10 mg, e 218 2.27 mg, glycerolum (85 per centum), sorbitolum 187 mg, macrogolum 4000, carmellosum natricum, acidum citricum monohydricum, natrii citras dihydricus, sucralosum, aromatica (erdbeer) cum propylenglycolum, maltolum, natrii chloridum, aqua purificata, ad solutionem pro 1 ml corresp. natrium max. 1.6 mg. - antiepileptikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - lacosamidum - compresse rivestite con film - lacosamidum 50 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, crospovidonum, hydroxypropylcellulosum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum, talcum, e 132, e 171, e 172 (rubrum), e 172 (nigrum) pro compresso obducto. - antiepileptikum - synthetika